ClinicalTrials.Veeva

Menu

Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Melanoma

R

Reinhard Dummer

Status

Completed

Conditions

Melanoma

Treatments

Other: Establishment of an in-deepth tumor profiling platform

Study type

Observational

Funder types

Other

Identifiers

NCT06463509
TUPRO-Melanoma

Details and patient eligibility

About

TUPRO-Melanoma is the first project of the Tumour Profiler (TUPRO) research collaboration, which in the long-term aims to generate data that will help to understand and report the individual tumour biology and the clinical parameters for patients with advanced malignancies using innovative molecular technologies and computational analyses for in-depth molecular profiling. TUPRO-Melanoma is an exploratory project that aims to establish a comprehensive platform for in-depth tumour profiling in patients suffering from advanced melanoma. Aims of this platform are to establish logistics and algorithms for integrative analyses and discover new molecular biomarker profiles/patterns.

Enrollment

116 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 years
  • ECOG performance status ≤2 (not bedridden for more than 50% of waking hours)
  • Stage III or IV cutaneous melanoma, or rare melanoma subtypes at any stage that require systemic therapy
  • Written informed consent according to national legal and regulatory requirements prior to any project specific procedures

Exclusion criteria

  • Any other serious underlying medical, psychiatric, psychological, familial or geographical condition, which in the judgment of the sponsor-project leader or site project leader may interfere with the project or affect patient compliance
  • Legal incompetence

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems